BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12130513)

  • 21. Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements.
    Homminga I; Vuerhard MJ; Langerak AW; Buijs-Gladdines J; Pieters R; Meijerink JP
    Haematologica; 2012 Feb; 97(2):258-61. PubMed ID: 22058201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of HOX11 in childhood T-lineage acute lymphoblastic leukaemia can occur in the absence of cytogenetic aberration at 10q24: a study from the Children's Cancer Group (CCG).
    Kees UR; Heerema NA; Kumar R; Watt PM; Baker DL; La MK; Uckun FM; Sather HN
    Leukemia; 2003 May; 17(5):887-93. PubMed ID: 12750702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia.
    van Zutven LJ; Velthuizen SC; Wolvers-Tettero IL; van Dongen JJ; Poulsen TS; MacLeod RA; Beverloo HB; Langerak AW
    Haematologica; 2004 Jun; 89(6):671-8. PubMed ID: 15194534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NKX2-5, SIL/TAL and TLX3/HOX11L2 expression in Egyptian pediatric T-cell acute lymphoblastic leukemia.
    Moussa H; Sidhom I
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e1-10. PubMed ID: 24571118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of minimal residual disease by PCR in childhood T-cell acute lymphoblastic leukemia with TAL1 gene rearrangement: a preliminary report.
    Kikuchi A; Hanada R; Yamamoto K; Hayashi Y
    Med Pediatr Oncol; 1999 Feb; 32(2):148. PubMed ID: 9950206
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
    Deleuze V; El-Hajj R; Chalhoub E; Dohet C; Pinet V; Couttet P; Mathieu D
    PLoS One; 2012; 7(7):e40484. PubMed ID: 22792348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols.
    van Grotel M; Meijerink JP; Beverloo HB; Langerak AW; Buys-Gladdines JG; Schneider P; Poulsen TS; den Boer ML; Horstmann M; Kamps WA; Veerman AJ; van Wering ER; van Noesel MM; Pieters R
    Haematologica; 2006 Sep; 91(9):1212-21. PubMed ID: 16956820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
    Hansson A; Manetopoulos C; Jönsson JI; Axelson H
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
    Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
    Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
    Smith S; Tripathi R; Goodings C; Cleveland S; Mathias E; Hardaway JA; Elliott N; Yi Y; Chen X; Downing J; Mullighan C; Swing DA; Tessarollo L; Li L; Love P; Jenkins NA; Copeland NG; Thompson MA; Du Y; Davé UP
    PLoS One; 2014; 9(1):e85883. PubMed ID: 24465765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype.
    Salvati PD; Ranford PR; Ford J; Kees UR
    Oncogene; 1995 Oct; 11(7):1333-8. PubMed ID: 7478554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1.
    Osada H; Grutz G; Axelson H; Forster A; Rabbitts TH
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9585-9. PubMed ID: 7568177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent clonal loss of heterozygosity (LOH) in the chromosomal region 1p32 occurs in childhood T cell acute lymphoblastic leukemia (T-ALL) carrying rearrangements of the TAL1 gene.
    Iolascon A; Faienza MF; Coppola B; Moretti A; Basso G; Amaru R; Viganò G; Biondi A
    Leukemia; 1997 Mar; 11(3):359-63. PubMed ID: 9067574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia.
    Bernard OA; Busson-LeConiat M; Ballerini P; Mauchauffé M; Della Valle V; Monni R; Nguyen Khac F; Mercher T; Penard-Lacronique V; Pasturaud P; Gressin L; Heilig R; Daniel MT; Lessard M; Berger R
    Leukemia; 2001 Oct; 15(10):1495-504. PubMed ID: 11587205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
    Curry JD; Smith MT
    Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1.
    Gering M; Yamada Y; Rabbitts TH; Patient RK
    Development; 2003 Dec; 130(25):6187-99. PubMed ID: 14602685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL).
    Lowsky R; DeCoteau JF; Reitmair AH; Ichinohasama R; Dong WF; Xu Y; Mak TW; Kadin ME; Minden MD
    Blood; 1997 Apr; 89(7):2276-82. PubMed ID: 9116269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin.
    Fischer S; Mann G; Konrad M; Metzler M; Ebetsberger G; Jones N; Nadel B; Bodamer O; Haas OA; Schmitt K; Panzer-Grümayer ER
    Blood; 2007 Oct; 110(8):3036-8. PubMed ID: 17557895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome.
    Mansur MB; Emerenciano M; Brewer L; Sant'Ana M; Mendonça N; Thuler LC; Koifman S; Pombo-de-Oliveira MS
    Leuk Lymphoma; 2009 Aug; 50(8):1318-25. PubMed ID: 19562638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.
    Aplan PD; Lombardi DP; Reaman GH; Sather HN; Hammond GD; Kirsch IR
    Blood; 1992 Mar; 79(5):1327-33. PubMed ID: 1311214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.